• Rucaparib (AG-014699): Enhancing DNA Damage Response Assays

  2026-05-20

  Rucaparib (AG-014699) unlocks advanced DNA damage response research by enabling targeted disruption of base excision repair and regulated cell death pathways. Discover protocol optimizations, comparative advantages, and troubleshooting strategies for maximizing assay validity and translational insight.

• O-GlcNAcylation Controls Ferroptosis and Syncytialization in

  2026-05-20

  The reference study reveals that O-GlcNAc modification of HUWE1 orchestrates the ubiquitination and degradation of TfR1, restricting ferroptosis and supporting trophoblast syncytialization in preeclampsia. These mechanistic insights highlight the O-GlcNAc–HUWE1–TfR1 axis as a promising therapeutic target for placental dysfunction.

• Nanoparticle-Mediated mRNA Delivery to Overcome Trastuzumab

  2026-05-19

  This article analyzes a recent study that developed tumor microenvironment-responsive nanoparticles for systemic mRNA delivery to reverse trastuzumab resistance in HER2-positive breast cancer. The work demonstrates how targeted PTEN mRNA delivery can restore drug sensitivity by modulating the PI3K/Akt pathway, offering a mechanistically informed approach to overcoming antibody therapy resistance.

• CRISPRi Targeting Fabp4 in Adipocytes: Advancing Obesity The

  2026-05-19

  This study presents a targeted CRISPR interference (CRISPRi) approach to silence Fabp4 in white adipocytes, significantly improving obesity-related metabolic parameters in mice. The findings highlight a precise, nonviral gene delivery system for adipose tissue, establishing a strong foundation for future metabolic disorder therapies.

• FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) in

  2026-05-18

  Unlock the full potential of mitochondrial uncoupling with FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone)—a gold-standard tool for dissecting oxidative phosphorylation and hypoxia-inducible factor signaling. Learn how robust workflows, data-backed parameters, and troubleshooting strategies can elevate your metabolic regulation studies.

• Machine Learning Predictions for Lipid Nanoparticle mRNA Del

  2026-05-18

  This study establishes a machine learning-based framework for predicting the performance of lipid nanoparticle (LNP) formulations in mRNA vaccine delivery. By integrating experimental data, predictive modeling, and molecular dynamics, the researchers identify critical structural features of ionizable lipids such as SM-102, offering a new avenue for accelerating mRNA vaccine development.

• Murine RNase Inhibitor: Next-Gen RNA Stability for Epitransc

  2026-05-17

  Explore the scientific foundation and advanced applications of Murine RNase Inhibitor in safeguarding RNA integrity for cutting-edge epitranscriptomic research. Discover what sets this RNase A inhibitor apart for modern molecular workflows.

• Nanobody Targeting PstS-1 in TB Granuloma: Diagnostic Potent

  2026-05-16

  Dhekale et al. (2025) report the isolation and characterization of a high-affinity nanobody specific to the PstS-1 protein of Mycobacterium tuberculosis, a promising biomarker for molecular imaging of tuberculosis granulomas. This advancement addresses limitations in current diagnostic tools, especially for low-bacillary or extrapulmonary TB, and lays groundwork for novel imaging-based detection strategies.

• Filipin III as a Quantitative Cholesterol Probe: Beyond Visu

  2026-05-15

  Explore how Filipin III, a polyene macrolide antibiotic, redefines quantitative cholesterol detection in membranes. This article reveals advanced assay strategies and translational insights, bridging molecular mechanism and disease relevance.

• Curcumin Inhibits H2O2-Induced Endothelial Pyroptosis via NL

  2026-05-15

  This study demonstrates that curcumin protects human umbilical vein endothelial cells (HUVECs) from hydrogen peroxide-induced pyroptosis by suppressing NLRP3 inflammasome activation. The findings clarify molecular mechanisms underlying endothelial dysfunction in atherosclerosis and provide validated pharmacological and assay strategies for dissecting inflammatory cell death.

• EHEC Herbal Extract Prevents Precocious Puberty in Danazol R

  2026-05-14

  This study demonstrates that a complex of Eclipta prostrata and Hordeum vulgare (EHEC) significantly delays the onset of precocious puberty in rats induced by Danazol and high-fat diet. The findings highlight a potential natural alternative for modulating the hypothalamic–pituitary–gonadal axis, with translational implications for endocrine research and disease modeling.

• Fenipentol (1-Phenyl-1-pentanol): Optimizing Pancreatic Secr

  2026-05-14

  Fenipentol, a bioactive choleretic agent, streamlines advanced workflows in gastrointestinal and hepatobiliary physiology studies. This guide translates recent anti-fibrotic evidence and historical clinical use into actionable protocols, troubleshooting, and comparative insight for experimental innovation.

• Safe DNA Gel Stain: Advanced Workflows for Nucleic Acid Dete

  2026-05-13

  Safe DNA Gel Stain delivers high-sensitivity DNA and RNA visualization with markedly reduced mutagenicity and DNA damage compared to ethidium bromide. Designed for blue-light or UV excitation, this APExBIO solution empowers molecular biologists to maximize data integrity, biosafety, and cloning efficiency in both routine and advanced experimental workflows.

• RWJ 67657: Structural Insights and Selectivity in p38 MAPK I

  2026-05-13

  Explore the unique selectivity and structural mechanism of RWJ 67657, a potent p38α/β MAP kinase inhibitor, and discover how new conformational insights empower advanced inflammatory disease research.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-05-12

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is intended exclusively for in vitro laboratory applications and should not be used for in vivo or clinical studies due to a lack of data.

15886 records 1/1060 page Next 12345 下5页 Last page